International Clinical Trial: A Multi-Center, Randomized, Double-Blind, Placebo Parallel Controlled Study to Evaluate the Efficacy and Safety of NT-002 Capsules to Treat Secondary Hyperparathyroidism in Chinese Subjects with Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126426) titled 'A Multi-Center, Randomized, Double-Blind, Placebo Parallel Controlled Study to Evaluate the Efficacy and Safety of NT-002 Capsules to Treat Secondary Hyperparathyroidism in Chinese Subjects with Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency' on June 9.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Dalian Medical University

Condition: Secondary Hyperparathyroidism

Intervention: Test group:NT-002 Capsules(oral use)

Recruitment Status: Not Recruiting

Phase: 3

Date of First Enrollment: 2023-08-03

Target Sample Size: Test group...